BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 10550295)

  • 1. Comparative genomic hybridization analysis of natural killer cell lymphoma/leukemia. Recognition of consistent patterns of genetic alterations.
    Siu LL; Wong KF; Chan JK; Kwong YL
    Am J Pathol; 1999 Nov; 155(5):1419-25. PubMed ID: 10550295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukemia: different genomic alteration patterns of aggressive NK-cell leukemia and extranodal Nk/T-cell lymphoma, nasal type.
    Nakashima Y; Tagawa H; Suzuki R; Karnan S; Karube K; Ohshima K; Muta K; Nawata H; Morishima Y; Nakamura S; Seto M
    Genes Chromosomes Cancer; 2005 Nov; 44(3):247-55. PubMed ID: 16049916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent patterns of allelic loss in natural killer cell lymphoma.
    Siu LL; Chan V; Chan JK; Wong KF; Liang R; Kwong YL
    Am J Pathol; 2000 Dec; 157(6):1803-9. PubMed ID: 11106552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative genomic hybridization study of nasal-type NK/T-cell lymphoma.
    Ko YH; Choi KE; Han JH; Kim JM; Ree HJ
    Cytometry; 2001 Apr; 46(2):85-91. PubMed ID: 11309817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement.
    Mao X; Onadim Z; Price EA; Child F; Lillington DM; Russell-Jones R; Young BD; Whittaker S
    J Invest Dermatol; 2003 Sep; 121(3):618-27. PubMed ID: 12925224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
    Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
    Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors engaged in development of NK cells are commonly expressed in nasal NK/T-cell lymphomas.
    Zhang S; Li T; Zhang B; Nong L; Aozasa K
    Hum Pathol; 2011 Sep; 42(9):1319-28. PubMed ID: 21329961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of the pathology, immunophenotype, etiology and genetic marker of NK/T-cell lymphoma].
    Zhong BN; Zhang XH; Li M; Cao HG; Li N; Liu CY; Gu YQ; Gao ZF
    Zhonghua Xue Ye Xue Za Zhi; 2003 Oct; 24(10):505-9. PubMed ID: 14690577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell malignancies: clinicopathologic and molecular features.
    Siu LL; Chan JK; Kwong YL
    Histol Histopathol; 2002 Apr; 17(2):539-54. PubMed ID: 11962758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases.
    Coupland SE; Foss HD; Assaf C; Auw-Haedrich C; Anastassiou G; Anagnostopoulos I; Hummel M; Karesh JW; Lee WR; Stein H
    Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extranodal natural killer/T-cell lymphoma, nasal type in Taiwan: a relatively higher frequency of T-cell lineage and poor survival for extranasal tumors.
    Jhuang JY; Chang ST; Weng SF; Pan ST; Chu PY; Hsieh PP; Wei CH; Chou SC; Koo CL; Chen CJ; Hsu JD; Chuang SS
    Hum Pathol; 2015 Feb; 46(2):313-21. PubMed ID: 25554090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human interleukin-10 expression in T/natural killer-cell lymphomas: association with anaplastic large cell lymphomas and nasal natural killer-cell lymphomas.
    Boulland ML; Meignin V; Leroy-Viard K; Copie-Bergman C; Brière J; Touitou R; Kanavaros P; Gaulard P
    Am J Pathol; 1998 Oct; 153(4):1229-37. PubMed ID: 9777954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans.
    Ko YH; Ree HJ; Kim WS; Choi WH; Moon WS; Kim SW
    Cancer; 2000 Nov; 89(10):2106-16. PubMed ID: 11066052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive T/natural killer cell lymphoma presenting as testicular tumor.
    Chan JK; Tsang WY; Lau WH; Cheung MM; Ng WF; Yuen WC; Ng CS
    Cancer; 1996 Mar; 77(6):1198-205. PubMed ID: 8635144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of chromosome 6q deletion in EBV-associated NK cell leukaemia/lymphoma.
    Ohshima K; Haraokaa S; Ishihara S; Ohgami A; Yoshioka S; Suzumiya J; Kikuchi M
    Leuk Lymphoma; 2002 Feb; 43(2):293-300. PubMed ID: 11999560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK and NK-like T-cell lymphoma in extranasal sites: a comparative clinicopathological study according to site and EBV status.
    Ko YH; Cho EY; Kim JE; Lee SS; Huh JR; Chang HK; Yang WI; Kim CW; Kim SW; Ree HJ
    Histopathology; 2004 May; 44(5):480-9. PubMed ID: 15139996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro.
    Iqbal J; Weisenburger DD; Chowdhury A; Tsai MY; Srivastava G; Greiner TC; Kucuk C; Deffenbacher K; Vose J; Smith L; Au WY; Nakamura S; Seto M; Delabie J; Berger F; Loong F; Ko YH; Sng I; Liu X; Loughran TP; Armitage J; Chan WC;
    Leukemia; 2011 Feb; 25(2):348-58. PubMed ID: 21052088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
    Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
    Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic aberrations in carcinomas of the uterine corpus.
    Micci F; Teixeira MR; Haugom L; Kristensen G; Abeler VM; Heim S
    Genes Chromosomes Cancer; 2004 Jul; 40(3):229-46. PubMed ID: 15139002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.